Tower Research Capital (TRC)’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $90.2K | Buy |
|
|||||
|
2025
Q4 | $12.2K | Sell |
|
|||||
|
2025
Q3 | $74.9K | Buy |
|
|||||
|
2025
Q2 | $110K | Buy |
|
|||||
|
2025
Q1 | $77.1K | Sell |
|
|||||
|
2024
Q4 | $481K | Buy |
|
|||||
|
2024
Q3 | $62.5K | Sell |
|
|||||
|
2024
Q2 | $65.4K | Buy |
|
|||||
|
2024
Q1 | $2.36K | Sell |
|
|||||
|
2023
Q4 | $38.7K | Sell |
|
|||||
|
2023
Q3 | $135K | Buy |
|
|||||
|
2023
Q2 | $63.7K | Sell |
|
|||||
|
2023
Q1 | $64K | Buy |
|
|||||
|
2022
Q4 | $70K | Buy |
|
|||||
|
2022
Q3 | $35K | Sell |
|
|||||
|
2022
Q2 | $45K | Sell |
|
|||||
|
2022
Q1 | $70K | Buy |
|
|||||
|
2021
Q4 | $19K | Sell |
|
|||||
|
2021
Q3 | $46K | Buy |
|
|||||
|
2021
Q2 | $34K | Buy |
|
|||||
|
2021
Q1 | $29K | Buy |
|